Kenneth B. Lee
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kenneth B. Lee
Earlier roles on record: Board Member at Hyperion Defi, Inc. (HYPD) until September 30, 2022 and Board Member at Biocryst Pharmaceuticals Inc (BCRX) until December 31, 2023. Hyperion Defi, Inc. reported in an 8-K filed September 30, 2022 that Kenneth B. Lee retired as Lead Independent Director, effective September 30, 2022.
“On September 30, 2022, Eyenovia, Inc. (the "Company") issued a press release announcing the retirement of Kenneth (Ken) B. Lee, Jr. from the Board of Directors (the "Board") and from the committees of the Board on which he served (Audit, Compensation and Nominating and Governance), effective as of September 30, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2018-01-01–2022-09-30
-
2011-01-01–2023-12-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.